Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Приверженность ПАП-терапии у больных с синдромом обструктивного апноэ сна и сердечно-сосудистыми заболеваниями
Приверженность ПАП-терапии у больных с синдромом обструктивного апноэ сна и сердечно-сосудистыми заболеваниями
Михайлова О.О., Елфимова Е.М., Литвин А.Ю., Чазова И.Е. Приверженность ПАП-терапии у больных с синдромом обструктивного апноэ сна и сердечно-сосудистыми заболеваниями. Системные гипертензии. 2020; 17 (4): 37–43. DOI: 10.26442/2075082X.2020.4. 200529
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Цель. Изучить длительную приверженность терапии положительным давлением в дыхательных путях (Positive Airway Pressure – ПАП-терапии) и ее влияние на характер течения различных сердечно-сосудистых заболеваний у больных с синдромом обструктивного апноэ сна.
Материалы и методы. В исследование включены 119 пациентов, наблюдавшихся в ФГБУ «НМИЦ кардиологии» в период с 2012 по 2020 г., с синдромом обструктивного апноэ сна различной степени тяжести и сердечно-сосудистыми заболеваниями (ССЗ), получающих ПАП-терапию (из них 93 человека, 78,2%, – мужчины). Медиана продолжительности наблюдения составила 3,0 года [1,5; 5,0]. За критерии приверженности приняты следующие: использование ПАП-аппарата на протяжении не менее 71% ночей в год и не менее 4 ч за ночь.
Результаты. В общей выборке больных с ССЗ 63,4% пациента привержены ПАП-терапии. Приверженные больные оказались старше по возрасту (64,0 года [58,5; 68,0] против 59,0 года [53,0; 65,0] соответственно, р=0,03) и имели более высокий индекс апноэ-гипопноэ – 47,7 соб/ч [37,5; 64,4] против 38,2 соб/ч [30,4; 52,7] соответственно, р=0,04.
Пациенты с артериальной гипертонией (АГ) III стадии значимо меньше используют ПАП-аппарат каждую ночь в сравнении с больными АГ I–II стадии (3,4 ч за ночь [1,1; 3,6] против 6,3 ч за ночь [5,3; 7,4] соответственно, р=0,00). Приверженность больных при наличии или отсутствии ишемической болезни сердца и пароксизмальной формы фибрилляции предсердий не различалась. Значимого различия по частоте развития III стадии АГ, ишемической болезни сердца, перехода пароксизмальной формы фибрилляции предсердий в постоянную между группами приверженных и неприверженных ПАП-терапии не выявлено.
Заключение. ПАП-терапии полностью привержены 63,4% больных с ССЗ. Приверженные лечению пациенты старше по возрасту и имеют более высокий индекс апноэ-гипопноэ. При наличии III стадии АГ приверженность ПАП-терапии ниже, чем при АГ меньших стадий. Характер течения различных ССЗ у приверженных и неприверженных пациентов не различался.
Ключевые слова: приверженность ПАП-терапии, синдром обструктивного апноэ сна.
Materials and methods. The study included 119 patients with obstructive sleep apnea (OSA) and cardiovascular diseases (CVD) who were followed up at the National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation in the period from 2012 to 2020, and have been receiving positive airway pressure (PAP) therapy (93 men, 78.2%). The median follow-up was 3.0 years [1.5; 5.0]. The adherence criteria were the following: the usage of the PAP device for at least 71% of nights a year, and at least 4 hours per night.
Results. 64.3% of patients met the criteria for adherence to PAP therapy (use more than 4 hours/night, more than 71% of nights). The adherent patients were older (64.0 years [58.5; 68.0] versus 59.0 years [53.0; 65.0] resp., p=0.03) and had a higher apnea-hypopnea index – AHI (47.7 events/h [37.5; 64.4] versus 38.2 events/h [30.4; 52.7] resp., p=0.04).
Patients with stage III of hypertension were using a PAP device every night significantly less (3.4 h/night [1.1; 3.6] versus 6.3 h/night [5.3; 7.4] respectively, p=0.00) – in comparison with patients with hypertension stages I–II. The adherence of patients with or without coronary artery disease (CAD) and paroxysmal atrial fibrillation (AF) did not differ. There was no significant difference in the incidence of stage III hypertension, CAD, and permanent AF between the groups of adherent and non-adherent to PAP therapy patients.
Conclusion. 63.4% of patients with CVD were adherent to PAP therapy. Adherent patients were older and had a higher AHI. Patients with stage III hypertension were worse adherent to PAP therapy in comparison with patients with hypertension of lesser stages. The CVDs course in adherent and non-adherent patients did not differ.
Key words: positive airway pressure therapy adherence, obstructive sleep apnea.
Материалы и методы. В исследование включены 119 пациентов, наблюдавшихся в ФГБУ «НМИЦ кардиологии» в период с 2012 по 2020 г., с синдромом обструктивного апноэ сна различной степени тяжести и сердечно-сосудистыми заболеваниями (ССЗ), получающих ПАП-терапию (из них 93 человека, 78,2%, – мужчины). Медиана продолжительности наблюдения составила 3,0 года [1,5; 5,0]. За критерии приверженности приняты следующие: использование ПАП-аппарата на протяжении не менее 71% ночей в год и не менее 4 ч за ночь.
Результаты. В общей выборке больных с ССЗ 63,4% пациента привержены ПАП-терапии. Приверженные больные оказались старше по возрасту (64,0 года [58,5; 68,0] против 59,0 года [53,0; 65,0] соответственно, р=0,03) и имели более высокий индекс апноэ-гипопноэ – 47,7 соб/ч [37,5; 64,4] против 38,2 соб/ч [30,4; 52,7] соответственно, р=0,04.
Пациенты с артериальной гипертонией (АГ) III стадии значимо меньше используют ПАП-аппарат каждую ночь в сравнении с больными АГ I–II стадии (3,4 ч за ночь [1,1; 3,6] против 6,3 ч за ночь [5,3; 7,4] соответственно, р=0,00). Приверженность больных при наличии или отсутствии ишемической болезни сердца и пароксизмальной формы фибрилляции предсердий не различалась. Значимого различия по частоте развития III стадии АГ, ишемической болезни сердца, перехода пароксизмальной формы фибрилляции предсердий в постоянную между группами приверженных и неприверженных ПАП-терапии не выявлено.
Заключение. ПАП-терапии полностью привержены 63,4% больных с ССЗ. Приверженные лечению пациенты старше по возрасту и имеют более высокий индекс апноэ-гипопноэ. При наличии III стадии АГ приверженность ПАП-терапии ниже, чем при АГ меньших стадий. Характер течения различных ССЗ у приверженных и неприверженных пациентов не различался.
Ключевые слова: приверженность ПАП-терапии, синдром обструктивного апноэ сна.
________________________________________________
Materials and methods. The study included 119 patients with obstructive sleep apnea (OSA) and cardiovascular diseases (CVD) who were followed up at the National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation in the period from 2012 to 2020, and have been receiving positive airway pressure (PAP) therapy (93 men, 78.2%). The median follow-up was 3.0 years [1.5; 5.0]. The adherence criteria were the following: the usage of the PAP device for at least 71% of nights a year, and at least 4 hours per night.
Results. 64.3% of patients met the criteria for adherence to PAP therapy (use more than 4 hours/night, more than 71% of nights). The adherent patients were older (64.0 years [58.5; 68.0] versus 59.0 years [53.0; 65.0] resp., p=0.03) and had a higher apnea-hypopnea index – AHI (47.7 events/h [37.5; 64.4] versus 38.2 events/h [30.4; 52.7] resp., p=0.04).
Patients with stage III of hypertension were using a PAP device every night significantly less (3.4 h/night [1.1; 3.6] versus 6.3 h/night [5.3; 7.4] respectively, p=0.00) – in comparison with patients with hypertension stages I–II. The adherence of patients with or without coronary artery disease (CAD) and paroxysmal atrial fibrillation (AF) did not differ. There was no significant difference in the incidence of stage III hypertension, CAD, and permanent AF between the groups of adherent and non-adherent to PAP therapy patients.
Conclusion. 63.4% of patients with CVD were adherent to PAP therapy. Adherent patients were older and had a higher AHI. Patients with stage III hypertension were worse adherent to PAP therapy in comparison with patients with hypertension of lesser stages. The CVDs course in adherent and non-adherent patients did not differ.
Key words: positive airway pressure therapy adherence, obstructive sleep apnea.
Полный текст
Список литературы
1. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008; 5 (2): 136–43.
2. Peppard PE, Young T, Barnet JH et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013; 177 (9): 1006–14. DOI: 10.1093/aje/kws342
3. Konecny T, Kuniyoshi FHS, Orban M et al. Under-diagnosis of sleep apnea in patients after acute myocardial infarction. J Am Coll Cardiol 2010; 56 (9): 742–3.
4. Mehra R, Benjamin EJ, Shahar E et al. Association of nocturnal arrhythmias with sleepdisordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006; 173 (8): 910–6.
5. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. New Engl J Med 2000; 342 (19): 1378–84.
6. Байрамбеков Э.Ш., Певзнер А.В., Литвин А.Ю., Елфимова Е.М. Возможности диагностики и частота выявления синдрома обструктивного апноэ во время сна у больных с различными формами фибрилляции предсердий. Кардиологический вестник. 2016; 11 (2): 34–41.
[Bairambekov E.Sh., Pevzner A.V., Litvin A.Yu., Elfimova E.M. Possibilities of diagnostics and the detection rate of obstructive sleep apnea in patients with various forms of atrial fibrillation. Russian Cardiology Bulletin. 2016; 11 (2): 34–41 (in Russian).]
7. Becker HF, Koehler U, Stammnitz A et al. Heart block in patients with sleep apnoea. Thorax 1998; 53 (Suppl. 3): S29–32.
8. Yaggi HK, Concato J, Kernan WN et al. Obstructive sleep apnea as a risk factor for stroke and death. New Eng J Med 2005; 353 (19): 2034–41.
9. Chan W, Coutts SB, Hanly P. Sleep Apnea in Patients With Transient Ischemic Attack and Minor Stroke. Stroke 2010; 41 (12): 2973–5.
10. Punjabi NM, Shahar E, Redline S et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004; 160 (6): 521–30.
11. Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Resp Crit Care Med 2005; 172 (12): 1590–5.
12. Drager LF, Lopes HF, Maki-Nunes C et al. The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS One 2010; (8): e12065.
13. Peppard PE, Szklo-Coxe M, Hla KM, Young T. Longitudinal association of sleep-related breathing disorder and depression. Arch Intern Med 2006; 166 (16): 170–15.
14. Finn L, Young T, Palta M, Fryback DG. Sleep-disordered breathing and self-reported general health status in the Wisconsin Sleep Cohort Study. Sleep 1998; 21 (7): 701–6.
15. Marshall NS, Wong KK, Cullen SR et al. Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the Busselton Health Study cohort. J Clin Sleep Med 2014; 10 (4): 355–62.
16. Punjabi NM, Caffo BS, Goodwin JL et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009; 6 (8): e1000132.
17. Patil SP, Ayappa IA, Caples SM et al. Treatment of adult obstructive sleep apnea with positive airway pressure: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med 2019; 15 (2): 301–34.
18. Usui K, Bradley TD, Spaak J et al. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 2005; 45: 2008–11.
19. Литвин А.Ю., Михайлова О.О., Елфимова Е.М. и др. Синдром обструктивного апноэ сна и сердечно-сосудистые события. Consilium Medicum. 2016; 18 (1): 83–7.
[Litvin A.Yu., Mikhailova O.O., Elfimova E.M.et al. Obstructive sleep apnea syndrome and arterial hypertension: bidirectional relationship. Consilium Medicum. 2016; 18 (1): 83–7 (in Russian).]
20. Nishihata Y, Takata Y, Usui Y et al. Continuous positive airway pressure treatment improves cardiovascular outcomes in elderly patients with cardiovascular disease and obstructive sleep apnea. Heart Vessels 2015; 30 (1): 61.
21. Jehan S, Farag M, Zizi F et al. Obstructive sleep apnea and stroke. Sleep Med Disord 2018; 2 (5): 120–5.
22. Abud R, Salgueiro M, Drake L et al. Efficacy of continuous positive airway pressure (CPAP) preventing type 2 diabetes mellitus in patients with obstructive sleep apnea hypopnea syndrome (OSAHS) and insulin resistance: a systematic review and meta-analysis. Sleep Med 2019; 62: 14–21. DOI: 10.1016/j.sleep.2018.12.017
23. Певзнер А.В., Байрамбеков Э.Ш., Литвин А.Ю. и др. Результаты применения терапии с созданием постоянного положительного давления воздуха в верхних дыхательных путях при лечении больных с фибрилляцией предсердий и синдромом обструктивного апноэ во время сна. Рос. кардиол. журн. 2017; 7: 111–6. DOI: 10.15829/1560-4071-2017-7-111-116
[Pevzner A.V., Bayrambekov E.S., Litvin A.Yu. et al. Results of continuous positive upper airway pressure treatment in patients with atrial fibrillation and obstructive sleep apnea. Rus J Cardiol. 2017; 7: 111–6 (in Russian). DOI: 10.15829/1560-4071-2017-7-111-116]
24. Dediu GN, Dumitrache-Rujinski S, Lungu R et al. Positive pressure therapy in patients with cardiac arrhythmias and obstructive sleep apnea. Pneumologia 2015; 64 (1): 18–22.
25. Fein AS, Shvilkin A, Shah D et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 2013; 62 (4): 300–5.
26. Labarca G, Saavedra D, Dreyse J et al. Efficacy of CPAP for Improvements in Sleepiness, Cognition, Mood, and Quality of Life in Elderly Patients With OSA: Systematic Review and Meta-analysis of Randomized Controlled Trials Chest 2020; 158 (2): 75–64. DOI: 10.1016/j.chest.2020.03.049
27. Batool-Anwar S, Goodwin JL, Kushida CA et al. Impact of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea (OSA). J Sleep Res 2016; 25 (6): 731–8. DOI: 10.1111/jsr.12430
28. Tregear S, Reston J, Schoelles K, Phillips B. Continuous positive airway pressure reduces risk of motor vehicle crash among drivers with obstructive sleep apnea: systematic review and meta-analysis. Sleep 2010; 33 (10): 1373–80. DOI: 10.1093/sleep/33.10.1373
29. Fu Y, Xia Y, Yi H et al. Meta-analysis of all-cause and cardiovascular mortality in obstructive sleep apnea with or without continuous positive airway pressure treatment. Sleep Breath 2017; 21 (1): 181–89. DOI: 10.1007/s11325-016-1393-1
30. McEvoy RD, Antic NA, Heeley E et al. CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea. N Engl J Med 2016; 375: 919–31. DOI: 10.1056/NEJMoa1606599
31. Barbe F, Duran-Cantolla J, Capote F et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010; 181: 718–26.
32. Martinez-Garcia MA, Capote F, Campos-Rodriguez F et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA 2013; 310: 2407–15.
33. Haentjens P, Van Meerhaeghe A, Moscariello A et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007; 167: 757–64.
34. Marin JM, Agusti A, Villar I et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA 2012; 307: 2169–76.
35. Campos-Rodriguez F, Martinez-Garcia MA, de la Cruz-Moron I et al. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study. Ann Intern Med 2012; 156: 115–22.
36. Martinez-Garcia MA, Campos-Rodriguez F, Catalan-Serra P et al. Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment: a prospective observational study. Am J Respir Crit Care Med 2012; 186: 909–16.
37. Wickwire EM, Lettieri CJ, Cairns AA, Collop NA. Maximizing positive airway pressure adherence in adults: a common-sense approach. Chest 2013; 144 (2): 680–93.
38. Sawyer AM, Gooneratne NS, Marcus CL et al. A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev 2011; 15 (6): 343–56.
39. Rotenberg BW, Murariu D, Pang KP. Trends in CPAP adherence over twenty years of data collection: a flattened curve. J Otolaryngol Head Neck Surg 2016; 45 (1): 43. DOI: 10.1186/s40463-016-0156-0
40. Nogueira JF, Poyares D, Simonelli G et al. Accessibility and adherence to positive airway pressure treatment in patients with obstructive sleep apnea: a multicenter study in Latin America. Sleep Breath 2020; 24 (2): 455–64. DOI: 10.1007/s11325-019-01881-9
41. Madbouly EM, Nadeem R, Nida M et al. The role of severity of obstructive sleep apnea measured by apnea-hypopnea index in predicting compliance with pressure therapy, a meta-analysis. Am J Ther 2014; 21 (4): 260–4. DOI: 10.1097/MJT.0b013e318249a09d
42. Billings ME, Auckley D, Benca R et al. Race and residential socioeconomics as predictors of CPAP adherence. Sleep 2011; 34: 1653–8.
43. Kohler M, Smith D, Tippett V, Stradling JR. Predictors of long-term compliance with continuous positive airway pressure. Thorax 2010; 65: 829–32.
44. Somers ML, Peterson E, Sharma S, Yaremchuk K. Continuous positive airway pressure adherence for obstructive sleep apnea. ISRN Otolaryngol 2011; 2011: 943586.
45. Queiroz DL, Yui MS, Braga AA et al. Adherence of obstructive sleep apnea syndrome patients to continuous positive airway pressure in a public service. Braz J Otorhinolaryngol 2014; 80: 126–30.
46. Riachy M, Najem S, Iskandar M et al. Factors predicting CPAP adherence in obstructive sleep apnea syndrome. Sleep Breath 2017; 21: 295–3.
47. Sopkova Z, Dorkova Z, Tkacova R. Predictors of compliance with continuous positive airway pressure treatment in patients with obstructive sleep apnea and metabolic syndrome. Wien Klin Wochenschr 2009; 121: 398–404.
48. Hussain SF, Irfan M, Waheed Z et al. Compliance with continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea among privately paying patients – a cross sectional study. BMC Pulm Med 2014; 14: 188.
49. May AM, Gharibeh T, Wang L et al. CPAP Adherence Predictors in a Randomized Trial of Moderate-to-Severe OSA Enriched With Women and Minorities. Chest 2018; 154 (3): 567–78. DOI: 10.1016/j.chest.2018.04.010
50. Woehrle H, Graml A, Weinreich G. Age- and gender-dependent adherence with continuous positive airway pressure therapy. Sleep Med 2011; 12 (10): 1034–6.
51. Budhiraja R, Kushida CA, Nichols DA et al. Impact of Randomization, Clinic Visits, and Medical and Psychiatric Cormorbidities on Continuous Positive Airway Pressure Adherence in Obstructive Sleep Apnea. J Clin Sleep Med 2016; 12 (3): 333–41. DOI: 10.5664/jcsm.5578
52. Nsair A, Hupin D, Chomette S et al. Factors Influencing Adherence to Auto-CPAP: An Observational Monocentric Study Comparing Patients With and Without Cardiovascular Diseases. Front Neurol 2019; 10: 801. DOI: 10.3389/fneur.2019.00801
53. Baratta F, Pastori D, Bucci T et al. Long-term prediction of adherence to continuous positive air pressure therapy for the treatment of moderate/severe obstructive sleep apnea syndrome. Sleep Med 2018; 43: 66–70. DOI: 10.1016/j.sleep.2017.09.032
54. Wickwire EM, Jobe SL, Oldstone LM et al. Lower socioeconomic status and co-morbid conditions are associated with reduced continuous positive airway pressure adherence among older adult medicare beneficiaries with obstructive sleep apnea. Sleep 2020; 43 (12): zsaa122. DOI: 10.1093/sleep/zsaa122
55. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365 (9464): 1046–53. DOI: 10.1016/S0140-6736(05)71141-7
2. Peppard PE, Young T, Barnet JH et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013; 177 (9): 1006–14. DOI: 10.1093/aje/kws342
3. Konecny T, Kuniyoshi FHS, Orban M et al. Under-diagnosis of sleep apnea in patients after acute myocardial infarction. J Am Coll Cardiol 2010; 56 (9): 742–3.
4. Mehra R, Benjamin EJ, Shahar E et al. Association of nocturnal arrhythmias with sleepdisordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006; 173 (8): 910–6.
5. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. New Engl J Med 2000; 342 (19): 1378–84.
6. Bairambekov E.Sh., Pevzner A.V., Litvin A.Yu., Elfimova E.M. Possibilities of diagnostics and the detection rate of obstructive sleep apnea in patients with various forms of atrial fibrillation. Russian Cardiology Bulletin. 2016; 11 (2): 34–41 (in Russian).
7. Becker HF, Koehler U, Stammnitz A et al. Heart block in patients with sleep apnoea. Thorax 1998; 53 (Suppl. 3): S29–32.
8. Yaggi HK, Concato J, Kernan WN et al. Obstructive sleep apnea as a risk factor for stroke and death. New Eng J Med 2005; 353 (19): 2034–41.
9. Chan W, Coutts SB, Hanly P. Sleep Apnea in Patients With Transient Ischemic Attack and Minor Stroke. Stroke 2010; 41 (12): 2973–5.
10. Punjabi NM, Shahar E, Redline S et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004; 160 (6): 521–30.
11. Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Resp Crit Care Med 2005; 172 (12): 1590–5.
12. Drager LF, Lopes HF, Maki-Nunes C et al. The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS One 2010; (8): e12065.
13. Peppard PE, Szklo-Coxe M, Hla KM, Young T. Longitudinal association of sleep-related breathing disorder and depression. Arch Intern Med 2006; 166 (16): 170–15.
14. Finn L, Young T, Palta M, Fryback DG. Sleep-disordered breathing and self-reported general health status in the Wisconsin Sleep Cohort Study. Sleep 1998; 21 (7): 701–6.
15. Marshall NS, Wong KK, Cullen SR et al. Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the Busselton Health Study cohort. J Clin Sleep Med 2014; 10 (4): 355–62.
16. Punjabi NM, Caffo BS, Goodwin JL et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009; 6 (8): e1000132.
17. Patil SP, Ayappa IA, Caples SM et al. Treatment of adult obstructive sleep apnea with positive airway pressure: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med 2019; 15 (2): 301–34.
18. Usui K, Bradley TD, Spaak J et al. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 2005; 45: 2008–11.
19. Litvin A.Yu., Mikhailova O.O., Elfimova E.M.et al. Obstructive sleep apnea syndrome and arterial hypertension: bidirectional relationship. Consilium Medicum. 2016; 18 (1): 83–7 (in Russian).
20. Nishihata Y, Takata Y, Usui Y et al. Continuous positive airway pressure treatment improves cardiovascular outcomes in elderly patients with cardiovascular disease and obstructive sleep apnea. Heart Vessels 2015; 30 (1): 61.
21. Jehan S, Farag M, Zizi F et al. Obstructive sleep apnea and stroke. Sleep Med Disord 2018; 2 (5): 120–5.
22. Abud R, Salgueiro M, Drake L et al. Efficacy of continuous positive airway pressure (CPAP) preventing type 2 diabetes mellitus in patients with obstructive sleep apnea hypopnea syndrome (OSAHS) and insulin resistance: a systematic review and meta-analysis. Sleep Med 2019; 62: 14–21. DOI: 10.1016/j.sleep.2018.12.017
23. Pevzner A.V., Bayrambekov E.S., Litvin A.Yu. et al. Results of continuous positive upper airway pressure treatment in patients with atrial fibrillation and obstructive sleep apnea. Rus J Cardiol. 2017; 7: 111–6 (in Russian). DOI: 10.15829/1560-4071-2017-7-111-116
24. Dediu GN, Dumitrache-Rujinski S, Lungu R et al. Positive pressure therapy in patients with cardiac arrhythmias and obstructive sleep apnea. Pneumologia 2015; 64 (1): 18–22.
25. Fein AS, Shvilkin A, Shah D et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 2013; 62 (4): 300–5.
26. Labarca G, Saavedra D, Dreyse J et al. Efficacy of CPAP for Improvements in Sleepiness, Cognition, Mood, and Quality of Life in Elderly Patients With OSA: Systematic Review and Meta-analysis of Randomized Controlled Trials Chest 2020; 158 (2): 75–64. DOI: 10.1016/j.chest.2020.03.049
27. Batool-Anwar S, Goodwin JL, Kushida CA et al. Impact of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea (OSA). J Sleep Res 2016; 25 (6): 731–8. DOI: 10.1111/jsr.12430
28. Tregear S, Reston J, Schoelles K, Phillips B. Continuous positive airway pressure reduces risk of motor vehicle crash among drivers with obstructive sleep apnea: systematic review and meta-analysis. Sleep 2010; 33 (10): 1373–80. DOI: 10.1093/sleep/33.10.1373
29. Fu Y, Xia Y, Yi H et al. Meta-analysis of all-cause and cardiovascular mortality in obstructive sleep apnea with or without continuous positive airway pressure treatment. Sleep Breath 2017; 21 (1): 181–89. DOI: 10.1007/s11325-016-1393-1
30. McEvoy RD, Antic NA, Heeley E et al. CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea. N Engl J Med 2016; 375: 919–31. DOI: 10.1056/NEJMoa1606599
31. Barbe F, Duran-Cantolla J, Capote F et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010; 181: 718–26.
32. Martinez-Garcia MA, Capote F, Campos-Rodriguez F et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA 2013; 310: 2407–15.
33. Haentjens P, Van Meerhaeghe A, Moscariello A et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007; 167: 757–64.
34. Marin JM, Agusti A, Villar I et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA 2012; 307: 2169–76.
35. Campos-Rodriguez F, Martinez-Garcia MA, de la Cruz-Moron I et al. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study. Ann Intern Med 2012; 156: 115–22.
36. Martinez-Garcia MA, Campos-Rodriguez F, Catalan-Serra P et al. Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment: a prospective observational study. Am J Respir Crit Care Med 2012; 186: 909–16.
37. Wickwire EM, Lettieri CJ, Cairns AA, Collop NA. Maximizing positive airway pressure adherence in adults: a common-sense approach. Chest 2013; 144 (2): 680–93.
38. Sawyer AM, Gooneratne NS, Marcus CL et al. A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev 2011; 15 (6): 343–56.
39. Rotenberg BW, Murariu D, Pang KP. Trends in CPAP adherence over twenty years of data collection: a flattened curve. J Otolaryngol Head Neck Surg 2016; 45 (1): 43. DOI: 10.1186/s40463-016-0156-0
40. Nogueira JF, Poyares D, Simonelli G et al. Accessibility and adherence to positive airway pressure treatment in patients with obstructive sleep apnea: a multicenter study in Latin America. Sleep Breath 2020; 24 (2): 455–64. DOI: 10.1007/s11325-019-01881-9
41. Madbouly EM, Nadeem R, Nida M et al. The role of severity of obstructive sleep apnea measured by apnea-hypopnea index in predicting compliance with pressure therapy, a meta-analysis. Am J Ther 2014; 21 (4): 260–4. DOI: 10.1097/MJT.0b013e318249a09d
42. Billings ME, Auckley D, Benca R et al. Race and residential socioeconomics as predictors of CPAP adherence. Sleep 2011; 34: 1653–8.
43. Kohler M, Smith D, Tippett V, Stradling JR. Predictors of long-term compliance with continuous positive airway pressure. Thorax 2010; 65: 829–32.
44. Somers ML, Peterson E, Sharma S, Yaremchuk K. Continuous positive airway pressure adherence for obstructive sleep apnea. ISRN Otolaryngol 2011; 2011: 943586.
45. Queiroz DL, Yui MS, Braga AA et al. Adherence of obstructive sleep apnea syndrome patients to continuous positive airway pressure in a public service. Braz J Otorhinolaryngol 2014; 80: 126–30.
46. Riachy M, Najem S, Iskandar M et al. Factors predicting CPAP adherence in obstructive sleep apnea syndrome. Sleep Breath 2017; 21: 295–3.
47. Sopkova Z, Dorkova Z, Tkacova R. Predictors of compliance with continuous positive airway pressure treatment in patients with obstructive sleep apnea and metabolic syndrome. Wien Klin Wochenschr 2009; 121: 398–404.
48. Hussain SF, Irfan M, Waheed Z et al. Compliance with continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea among privately paying patients – a cross sectional study. BMC Pulm Med 2014; 14: 188.
49. May AM, Gharibeh T, Wang L et al. CPAP Adherence Predictors in a Randomized Trial of Moderate-to-Severe OSA Enriched With Women and Minorities. Chest 2018; 154 (3): 567–78. DOI: 10.1016/j.chest.2018.04.010
50. Woehrle H, Graml A, Weinreich G. Age- and gender-dependent adherence with continuous positive airway pressure therapy. Sleep Med 2011; 12 (10): 1034–6.
51. Budhiraja R, Kushida CA, Nichols DA et al. Impact of Randomization, Clinic Visits, and Medical and Psychiatric Cormorbidities on Continuous Positive Airway Pressure Adherence in Obstructive Sleep Apnea. J Clin Sleep Med 2016; 12 (3): 333–41. DOI: 10.5664/jcsm.5578
52. Nsair A, Hupin D, Chomette S et al. Factors Influencing Adherence to Auto-CPAP: An Observational Monocentric Study Comparing Patients With and Without Cardiovascular Diseases. Front Neurol 2019; 10: 801. DOI: 10.3389/fneur.2019.00801
53. Baratta F, Pastori D, Bucci T et al. Long-term prediction of adherence to continuous positive air pressure therapy for the treatment of moderate/severe obstructive sleep apnea syndrome. Sleep Med 2018; 43: 66–70. DOI: 10.1016/j.sleep.2017.09.032
54. Wickwire EM, Jobe SL, Oldstone LM et al. Lower socioeconomic status and co-morbid conditions are associated with reduced continuous positive airway pressure adherence among older adult medicare beneficiaries with obstructive sleep apnea. Sleep 2020; 43 (12): zsaa122. DOI: 10.1093/sleep/zsaa122
55. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365 (9464): 1046–53. DOI: 10.1016/S0140-6736(05)71141-7
2. Peppard PE, Young T, Barnet JH et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013; 177 (9): 1006–14. DOI: 10.1093/aje/kws342
3. Konecny T, Kuniyoshi FHS, Orban M et al. Under-diagnosis of sleep apnea in patients after acute myocardial infarction. J Am Coll Cardiol 2010; 56 (9): 742–3.
4. Mehra R, Benjamin EJ, Shahar E et al. Association of nocturnal arrhythmias with sleepdisordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006; 173 (8): 910–6.
5. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. New Engl J Med 2000; 342 (19): 1378–84.
6. Байрамбеков Э.Ш., Певзнер А.В., Литвин А.Ю., Елфимова Е.М. Возможности диагностики и частота выявления синдрома обструктивного апноэ во время сна у больных с различными формами фибрилляции предсердий. Кардиологический вестник. 2016; 11 (2): 34–41.
[Bairambekov E.Sh., Pevzner A.V., Litvin A.Yu., Elfimova E.M. Possibilities of diagnostics and the detection rate of obstructive sleep apnea in patients with various forms of atrial fibrillation. Russian Cardiology Bulletin. 2016; 11 (2): 34–41 (in Russian).]
7. Becker HF, Koehler U, Stammnitz A et al. Heart block in patients with sleep apnoea. Thorax 1998; 53 (Suppl. 3): S29–32.
8. Yaggi HK, Concato J, Kernan WN et al. Obstructive sleep apnea as a risk factor for stroke and death. New Eng J Med 2005; 353 (19): 2034–41.
9. Chan W, Coutts SB, Hanly P. Sleep Apnea in Patients With Transient Ischemic Attack and Minor Stroke. Stroke 2010; 41 (12): 2973–5.
10. Punjabi NM, Shahar E, Redline S et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004; 160 (6): 521–30.
11. Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Resp Crit Care Med 2005; 172 (12): 1590–5.
12. Drager LF, Lopes HF, Maki-Nunes C et al. The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS One 2010; (8): e12065.
13. Peppard PE, Szklo-Coxe M, Hla KM, Young T. Longitudinal association of sleep-related breathing disorder and depression. Arch Intern Med 2006; 166 (16): 170–15.
14. Finn L, Young T, Palta M, Fryback DG. Sleep-disordered breathing and self-reported general health status in the Wisconsin Sleep Cohort Study. Sleep 1998; 21 (7): 701–6.
15. Marshall NS, Wong KK, Cullen SR et al. Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the Busselton Health Study cohort. J Clin Sleep Med 2014; 10 (4): 355–62.
16. Punjabi NM, Caffo BS, Goodwin JL et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009; 6 (8): e1000132.
17. Patil SP, Ayappa IA, Caples SM et al. Treatment of adult obstructive sleep apnea with positive airway pressure: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med 2019; 15 (2): 301–34.
18. Usui K, Bradley TD, Spaak J et al. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 2005; 45: 2008–11.
19. Литвин А.Ю., Михайлова О.О., Елфимова Е.М. и др. Синдром обструктивного апноэ сна и сердечно-сосудистые события. Consilium Medicum. 2016; 18 (1): 83–7.
[Litvin A.Yu., Mikhailova O.O., Elfimova E.M.et al. Obstructive sleep apnea syndrome and arterial hypertension: bidirectional relationship. Consilium Medicum. 2016; 18 (1): 83–7 (in Russian).]
20. Nishihata Y, Takata Y, Usui Y et al. Continuous positive airway pressure treatment improves cardiovascular outcomes in elderly patients with cardiovascular disease and obstructive sleep apnea. Heart Vessels 2015; 30 (1): 61.
21. Jehan S, Farag M, Zizi F et al. Obstructive sleep apnea and stroke. Sleep Med Disord 2018; 2 (5): 120–5.
22. Abud R, Salgueiro M, Drake L et al. Efficacy of continuous positive airway pressure (CPAP) preventing type 2 diabetes mellitus in patients with obstructive sleep apnea hypopnea syndrome (OSAHS) and insulin resistance: a systematic review and meta-analysis. Sleep Med 2019; 62: 14–21. DOI: 10.1016/j.sleep.2018.12.017
23. Певзнер А.В., Байрамбеков Э.Ш., Литвин А.Ю. и др. Результаты применения терапии с созданием постоянного положительного давления воздуха в верхних дыхательных путях при лечении больных с фибрилляцией предсердий и синдромом обструктивного апноэ во время сна. Рос. кардиол. журн. 2017; 7: 111–6. DOI: 10.15829/1560-4071-2017-7-111-116
[Pevzner A.V., Bayrambekov E.S., Litvin A.Yu. et al. Results of continuous positive upper airway pressure treatment in patients with atrial fibrillation and obstructive sleep apnea. Rus J Cardiol. 2017; 7: 111–6 (in Russian). DOI: 10.15829/1560-4071-2017-7-111-116]
24. Dediu GN, Dumitrache-Rujinski S, Lungu R et al. Positive pressure therapy in patients with cardiac arrhythmias and obstructive sleep apnea. Pneumologia 2015; 64 (1): 18–22.
25. Fein AS, Shvilkin A, Shah D et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 2013; 62 (4): 300–5.
26. Labarca G, Saavedra D, Dreyse J et al. Efficacy of CPAP for Improvements in Sleepiness, Cognition, Mood, and Quality of Life in Elderly Patients With OSA: Systematic Review and Meta-analysis of Randomized Controlled Trials Chest 2020; 158 (2): 75–64. DOI: 10.1016/j.chest.2020.03.049
27. Batool-Anwar S, Goodwin JL, Kushida CA et al. Impact of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea (OSA). J Sleep Res 2016; 25 (6): 731–8. DOI: 10.1111/jsr.12430
28. Tregear S, Reston J, Schoelles K, Phillips B. Continuous positive airway pressure reduces risk of motor vehicle crash among drivers with obstructive sleep apnea: systematic review and meta-analysis. Sleep 2010; 33 (10): 1373–80. DOI: 10.1093/sleep/33.10.1373
29. Fu Y, Xia Y, Yi H et al. Meta-analysis of all-cause and cardiovascular mortality in obstructive sleep apnea with or without continuous positive airway pressure treatment. Sleep Breath 2017; 21 (1): 181–89. DOI: 10.1007/s11325-016-1393-1
30. McEvoy RD, Antic NA, Heeley E et al. CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea. N Engl J Med 2016; 375: 919–31. DOI: 10.1056/NEJMoa1606599
31. Barbe F, Duran-Cantolla J, Capote F et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010; 181: 718–26.
32. Martinez-Garcia MA, Capote F, Campos-Rodriguez F et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA 2013; 310: 2407–15.
33. Haentjens P, Van Meerhaeghe A, Moscariello A et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007; 167: 757–64.
34. Marin JM, Agusti A, Villar I et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA 2012; 307: 2169–76.
35. Campos-Rodriguez F, Martinez-Garcia MA, de la Cruz-Moron I et al. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study. Ann Intern Med 2012; 156: 115–22.
36. Martinez-Garcia MA, Campos-Rodriguez F, Catalan-Serra P et al. Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment: a prospective observational study. Am J Respir Crit Care Med 2012; 186: 909–16.
37. Wickwire EM, Lettieri CJ, Cairns AA, Collop NA. Maximizing positive airway pressure adherence in adults: a common-sense approach. Chest 2013; 144 (2): 680–93.
38. Sawyer AM, Gooneratne NS, Marcus CL et al. A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev 2011; 15 (6): 343–56.
39. Rotenberg BW, Murariu D, Pang KP. Trends in CPAP adherence over twenty years of data collection: a flattened curve. J Otolaryngol Head Neck Surg 2016; 45 (1): 43. DOI: 10.1186/s40463-016-0156-0
40. Nogueira JF, Poyares D, Simonelli G et al. Accessibility and adherence to positive airway pressure treatment in patients with obstructive sleep apnea: a multicenter study in Latin America. Sleep Breath 2020; 24 (2): 455–64. DOI: 10.1007/s11325-019-01881-9
41. Madbouly EM, Nadeem R, Nida M et al. The role of severity of obstructive sleep apnea measured by apnea-hypopnea index in predicting compliance with pressure therapy, a meta-analysis. Am J Ther 2014; 21 (4): 260–4. DOI: 10.1097/MJT.0b013e318249a09d
42. Billings ME, Auckley D, Benca R et al. Race and residential socioeconomics as predictors of CPAP adherence. Sleep 2011; 34: 1653–8.
43. Kohler M, Smith D, Tippett V, Stradling JR. Predictors of long-term compliance with continuous positive airway pressure. Thorax 2010; 65: 829–32.
44. Somers ML, Peterson E, Sharma S, Yaremchuk K. Continuous positive airway pressure adherence for obstructive sleep apnea. ISRN Otolaryngol 2011; 2011: 943586.
45. Queiroz DL, Yui MS, Braga AA et al. Adherence of obstructive sleep apnea syndrome patients to continuous positive airway pressure in a public service. Braz J Otorhinolaryngol 2014; 80: 126–30.
46. Riachy M, Najem S, Iskandar M et al. Factors predicting CPAP adherence in obstructive sleep apnea syndrome. Sleep Breath 2017; 21: 295–3.
47. Sopkova Z, Dorkova Z, Tkacova R. Predictors of compliance with continuous positive airway pressure treatment in patients with obstructive sleep apnea and metabolic syndrome. Wien Klin Wochenschr 2009; 121: 398–404.
48. Hussain SF, Irfan M, Waheed Z et al. Compliance with continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea among privately paying patients – a cross sectional study. BMC Pulm Med 2014; 14: 188.
49. May AM, Gharibeh T, Wang L et al. CPAP Adherence Predictors in a Randomized Trial of Moderate-to-Severe OSA Enriched With Women and Minorities. Chest 2018; 154 (3): 567–78. DOI: 10.1016/j.chest.2018.04.010
50. Woehrle H, Graml A, Weinreich G. Age- and gender-dependent adherence with continuous positive airway pressure therapy. Sleep Med 2011; 12 (10): 1034–6.
51. Budhiraja R, Kushida CA, Nichols DA et al. Impact of Randomization, Clinic Visits, and Medical and Psychiatric Cormorbidities on Continuous Positive Airway Pressure Adherence in Obstructive Sleep Apnea. J Clin Sleep Med 2016; 12 (3): 333–41. DOI: 10.5664/jcsm.5578
52. Nsair A, Hupin D, Chomette S et al. Factors Influencing Adherence to Auto-CPAP: An Observational Monocentric Study Comparing Patients With and Without Cardiovascular Diseases. Front Neurol 2019; 10: 801. DOI: 10.3389/fneur.2019.00801
53. Baratta F, Pastori D, Bucci T et al. Long-term prediction of adherence to continuous positive air pressure therapy for the treatment of moderate/severe obstructive sleep apnea syndrome. Sleep Med 2018; 43: 66–70. DOI: 10.1016/j.sleep.2017.09.032
54. Wickwire EM, Jobe SL, Oldstone LM et al. Lower socioeconomic status and co-morbid conditions are associated with reduced continuous positive airway pressure adherence among older adult medicare beneficiaries with obstructive sleep apnea. Sleep 2020; 43 (12): zsaa122. DOI: 10.1093/sleep/zsaa122
55. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365 (9464): 1046–53. DOI: 10.1016/S0140-6736(05)71141-7
________________________________________________
2. Peppard PE, Young T, Barnet JH et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013; 177 (9): 1006–14. DOI: 10.1093/aje/kws342
3. Konecny T, Kuniyoshi FHS, Orban M et al. Under-diagnosis of sleep apnea in patients after acute myocardial infarction. J Am Coll Cardiol 2010; 56 (9): 742–3.
4. Mehra R, Benjamin EJ, Shahar E et al. Association of nocturnal arrhythmias with sleepdisordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006; 173 (8): 910–6.
5. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. New Engl J Med 2000; 342 (19): 1378–84.
6. Bairambekov E.Sh., Pevzner A.V., Litvin A.Yu., Elfimova E.M. Possibilities of diagnostics and the detection rate of obstructive sleep apnea in patients with various forms of atrial fibrillation. Russian Cardiology Bulletin. 2016; 11 (2): 34–41 (in Russian).
7. Becker HF, Koehler U, Stammnitz A et al. Heart block in patients with sleep apnoea. Thorax 1998; 53 (Suppl. 3): S29–32.
8. Yaggi HK, Concato J, Kernan WN et al. Obstructive sleep apnea as a risk factor for stroke and death. New Eng J Med 2005; 353 (19): 2034–41.
9. Chan W, Coutts SB, Hanly P. Sleep Apnea in Patients With Transient Ischemic Attack and Minor Stroke. Stroke 2010; 41 (12): 2973–5.
10. Punjabi NM, Shahar E, Redline S et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004; 160 (6): 521–30.
11. Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Resp Crit Care Med 2005; 172 (12): 1590–5.
12. Drager LF, Lopes HF, Maki-Nunes C et al. The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS One 2010; (8): e12065.
13. Peppard PE, Szklo-Coxe M, Hla KM, Young T. Longitudinal association of sleep-related breathing disorder and depression. Arch Intern Med 2006; 166 (16): 170–15.
14. Finn L, Young T, Palta M, Fryback DG. Sleep-disordered breathing and self-reported general health status in the Wisconsin Sleep Cohort Study. Sleep 1998; 21 (7): 701–6.
15. Marshall NS, Wong KK, Cullen SR et al. Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the Busselton Health Study cohort. J Clin Sleep Med 2014; 10 (4): 355–62.
16. Punjabi NM, Caffo BS, Goodwin JL et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009; 6 (8): e1000132.
17. Patil SP, Ayappa IA, Caples SM et al. Treatment of adult obstructive sleep apnea with positive airway pressure: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med 2019; 15 (2): 301–34.
18. Usui K, Bradley TD, Spaak J et al. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 2005; 45: 2008–11.
19. Litvin A.Yu., Mikhailova O.O., Elfimova E.M.et al. Obstructive sleep apnea syndrome and arterial hypertension: bidirectional relationship. Consilium Medicum. 2016; 18 (1): 83–7 (in Russian).
20. Nishihata Y, Takata Y, Usui Y et al. Continuous positive airway pressure treatment improves cardiovascular outcomes in elderly patients with cardiovascular disease and obstructive sleep apnea. Heart Vessels 2015; 30 (1): 61.
21. Jehan S, Farag M, Zizi F et al. Obstructive sleep apnea and stroke. Sleep Med Disord 2018; 2 (5): 120–5.
22. Abud R, Salgueiro M, Drake L et al. Efficacy of continuous positive airway pressure (CPAP) preventing type 2 diabetes mellitus in patients with obstructive sleep apnea hypopnea syndrome (OSAHS) and insulin resistance: a systematic review and meta-analysis. Sleep Med 2019; 62: 14–21. DOI: 10.1016/j.sleep.2018.12.017
23. Pevzner A.V., Bayrambekov E.S., Litvin A.Yu. et al. Results of continuous positive upper airway pressure treatment in patients with atrial fibrillation and obstructive sleep apnea. Rus J Cardiol. 2017; 7: 111–6 (in Russian). DOI: 10.15829/1560-4071-2017-7-111-116
24. Dediu GN, Dumitrache-Rujinski S, Lungu R et al. Positive pressure therapy in patients with cardiac arrhythmias and obstructive sleep apnea. Pneumologia 2015; 64 (1): 18–22.
25. Fein AS, Shvilkin A, Shah D et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 2013; 62 (4): 300–5.
26. Labarca G, Saavedra D, Dreyse J et al. Efficacy of CPAP for Improvements in Sleepiness, Cognition, Mood, and Quality of Life in Elderly Patients With OSA: Systematic Review and Meta-analysis of Randomized Controlled Trials Chest 2020; 158 (2): 75–64. DOI: 10.1016/j.chest.2020.03.049
27. Batool-Anwar S, Goodwin JL, Kushida CA et al. Impact of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea (OSA). J Sleep Res 2016; 25 (6): 731–8. DOI: 10.1111/jsr.12430
28. Tregear S, Reston J, Schoelles K, Phillips B. Continuous positive airway pressure reduces risk of motor vehicle crash among drivers with obstructive sleep apnea: systematic review and meta-analysis. Sleep 2010; 33 (10): 1373–80. DOI: 10.1093/sleep/33.10.1373
29. Fu Y, Xia Y, Yi H et al. Meta-analysis of all-cause and cardiovascular mortality in obstructive sleep apnea with or without continuous positive airway pressure treatment. Sleep Breath 2017; 21 (1): 181–89. DOI: 10.1007/s11325-016-1393-1
30. McEvoy RD, Antic NA, Heeley E et al. CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea. N Engl J Med 2016; 375: 919–31. DOI: 10.1056/NEJMoa1606599
31. Barbe F, Duran-Cantolla J, Capote F et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010; 181: 718–26.
32. Martinez-Garcia MA, Capote F, Campos-Rodriguez F et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA 2013; 310: 2407–15.
33. Haentjens P, Van Meerhaeghe A, Moscariello A et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007; 167: 757–64.
34. Marin JM, Agusti A, Villar I et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA 2012; 307: 2169–76.
35. Campos-Rodriguez F, Martinez-Garcia MA, de la Cruz-Moron I et al. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study. Ann Intern Med 2012; 156: 115–22.
36. Martinez-Garcia MA, Campos-Rodriguez F, Catalan-Serra P et al. Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment: a prospective observational study. Am J Respir Crit Care Med 2012; 186: 909–16.
37. Wickwire EM, Lettieri CJ, Cairns AA, Collop NA. Maximizing positive airway pressure adherence in adults: a common-sense approach. Chest 2013; 144 (2): 680–93.
38. Sawyer AM, Gooneratne NS, Marcus CL et al. A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev 2011; 15 (6): 343–56.
39. Rotenberg BW, Murariu D, Pang KP. Trends in CPAP adherence over twenty years of data collection: a flattened curve. J Otolaryngol Head Neck Surg 2016; 45 (1): 43. DOI: 10.1186/s40463-016-0156-0
40. Nogueira JF, Poyares D, Simonelli G et al. Accessibility and adherence to positive airway pressure treatment in patients with obstructive sleep apnea: a multicenter study in Latin America. Sleep Breath 2020; 24 (2): 455–64. DOI: 10.1007/s11325-019-01881-9
41. Madbouly EM, Nadeem R, Nida M et al. The role of severity of obstructive sleep apnea measured by apnea-hypopnea index in predicting compliance with pressure therapy, a meta-analysis. Am J Ther 2014; 21 (4): 260–4. DOI: 10.1097/MJT.0b013e318249a09d
42. Billings ME, Auckley D, Benca R et al. Race and residential socioeconomics as predictors of CPAP adherence. Sleep 2011; 34: 1653–8.
43. Kohler M, Smith D, Tippett V, Stradling JR. Predictors of long-term compliance with continuous positive airway pressure. Thorax 2010; 65: 829–32.
44. Somers ML, Peterson E, Sharma S, Yaremchuk K. Continuous positive airway pressure adherence for obstructive sleep apnea. ISRN Otolaryngol 2011; 2011: 943586.
45. Queiroz DL, Yui MS, Braga AA et al. Adherence of obstructive sleep apnea syndrome patients to continuous positive airway pressure in a public service. Braz J Otorhinolaryngol 2014; 80: 126–30.
46. Riachy M, Najem S, Iskandar M et al. Factors predicting CPAP adherence in obstructive sleep apnea syndrome. Sleep Breath 2017; 21: 295–3.
47. Sopkova Z, Dorkova Z, Tkacova R. Predictors of compliance with continuous positive airway pressure treatment in patients with obstructive sleep apnea and metabolic syndrome. Wien Klin Wochenschr 2009; 121: 398–404.
48. Hussain SF, Irfan M, Waheed Z et al. Compliance with continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea among privately paying patients – a cross sectional study. BMC Pulm Med 2014; 14: 188.
49. May AM, Gharibeh T, Wang L et al. CPAP Adherence Predictors in a Randomized Trial of Moderate-to-Severe OSA Enriched With Women and Minorities. Chest 2018; 154 (3): 567–78. DOI: 10.1016/j.chest.2018.04.010
50. Woehrle H, Graml A, Weinreich G. Age- and gender-dependent adherence with continuous positive airway pressure therapy. Sleep Med 2011; 12 (10): 1034–6.
51. Budhiraja R, Kushida CA, Nichols DA et al. Impact of Randomization, Clinic Visits, and Medical and Psychiatric Cormorbidities on Continuous Positive Airway Pressure Adherence in Obstructive Sleep Apnea. J Clin Sleep Med 2016; 12 (3): 333–41. DOI: 10.5664/jcsm.5578
52. Nsair A, Hupin D, Chomette S et al. Factors Influencing Adherence to Auto-CPAP: An Observational Monocentric Study Comparing Patients With and Without Cardiovascular Diseases. Front Neurol 2019; 10: 801. DOI: 10.3389/fneur.2019.00801
53. Baratta F, Pastori D, Bucci T et al. Long-term prediction of adherence to continuous positive air pressure therapy for the treatment of moderate/severe obstructive sleep apnea syndrome. Sleep Med 2018; 43: 66–70. DOI: 10.1016/j.sleep.2017.09.032
54. Wickwire EM, Jobe SL, Oldstone LM et al. Lower socioeconomic status and co-morbid conditions are associated with reduced continuous positive airway pressure adherence among older adult medicare beneficiaries with obstructive sleep apnea. Sleep 2020; 43 (12): zsaa122. DOI: 10.1093/sleep/zsaa122
55. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365 (9464): 1046–53. DOI: 10.1016/S0140-6736(05)71141-7
Авторы
О.О. Михайлова1, Е.М. Елфимова1, А.Ю. Литвин*1,2, И.Е. Чазова1
1 Институт клинической кардиологии им. А.Л. Мясникова ФГБУ «Национальный медицинский исследовательский центр кардиологии» Минздрава России, Москва, Россия;
2 ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России, Москва, Россия
*alelitvin@yandex.ru
1 Myasnikov Institute of Clinical Cardiology, National Medical Research Center of Cardiology, Moscow, Russia;
2 Pirogov Russian National Research Medical University, Moscow, Russia
*alelitvin@yandex.ru
1 Институт клинической кардиологии им. А.Л. Мясникова ФГБУ «Национальный медицинский исследовательский центр кардиологии» Минздрава России, Москва, Россия;
2 ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России, Москва, Россия
*alelitvin@yandex.ru
________________________________________________
1 Myasnikov Institute of Clinical Cardiology, National Medical Research Center of Cardiology, Moscow, Russia;
2 Pirogov Russian National Research Medical University, Moscow, Russia
*alelitvin@yandex.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.